Tech Company Financing Transactions
Therna Biosciences Funding Round
On 8/26/2025, Therna Biosciences raised $10 million in Seed financing from AIX Ventures, Fusion Fund and Pear VC.
Transaction Overview
Company Name
Announced On
8/26/2025
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA Undisclosed
USA
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
Therna is pioneering a new era of programmable RNA therapeutics by integrating deep RNA biology with generative AI. Our platform explores RNA sequence space to express, silence, or fine tune genes. It can design custom mRNAs with coveted therapeutic properties and identify target regions of mRNA for optimal ASO/siRNA design.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Nazli Azimi
Browse more venture capital transactions:
Prev: 8/26/2025: Reframe Systems venture capital transaction
Next: 8/26/2025: Kiavi venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs